Format

Send to

Choose Destination
Am J Cardiol. 2001 Mar 1;87(5):627-30, A9.

Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2.

Author information

1
Genentech Inc, South San Francisco, California, USA. bangeja@medicine.ucsf.edu

Abstract

In a retrospective cohort of patients treated in community hospitals, tissue plasminogen activator (t-PA) was associated with decreased odds of in-hospital death or nonfatal stroke. However, the relative benefit was less evident in older patients and women, and some older subgroups did not benefit from treatment.

PMID:
11230850
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center